Enhanced TDS
Identification & Functionality
- Chemical Name
- Molecular formula
- C₁₉H₁₈ClN₃O₅S
- Technologies
- Product Families
- Definition
Rivaroxaban contains NLT 98.0% and NMT 102.0% of rivaroxaban (C19H18ClN3O5S), calculated on the anhydrous basis.
Applications & Uses
Properties
- Typical Properties
Value Units Test Method / Conditions Molecular Weight 435.88 - -
Regulatory & Compliance
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- USP Reference Standards
USP Rivaroxaban RS
USP Rivaroxaban R-Enantiomer RS
(R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide.
C19H18CIN3O5S 435.88
USP Rivaroxaban Related Compound B RS(S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide.
C16H19N3O5 333.34
USP Rivaroxaban Related Compound D RS 1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl] oxazolidin-5-yl}methyl)urea.
C29H32N6O9 608.61
USP Rivaroxaban Related Compound G RS(S)-2-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione.
C22H19N3O6 421.41
USP Rivaroxaban Related Compound J RS5-Chloro-N-(4-{(S)-5-[(5-chlorothiophene-2-carboxamido)methyl]-2-oxooxazolidin-3-yl}phenyl)-N-(2-{2-oxo-2-[({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)amino]ethoxy}ethyl)thiophene-2-carboxamide.
C38H36CI2N60O10S2 871.76 (USP 1-Dec-2022)
Storage & Handling
- Chemical Structure
- Storage Information
Preserve in tight, light-resistant containers at controlled room temperature. Keep away from heat and moisture.